New hope for patients with Werner syndrome
Werner syndrome (WS) is a rare genetic disorder that leads to premature aging and severe complications. In the first clinical trial of its kind, researchers from Japan, along with the company Niagen Bioscience, investigated the effect of nicotinamide riboside (NR), a vitamin B3 derivative, in patients with WS. NR intake significantly improved cardiovascular health, reduced the area of skin ulcers, and slowed the decline in kidney function – showing promising therapeutic potential for a disease that currently has no effective treatment. Werner syndrome (WS) is a rare genetic disorder that leads to an accelerated aging process. From the age of twenty, patients develop gray hair, hair loss, cataracts, diabetes, and other age-related conditions that normally occur in older people. In addition, patients develop severe and untreatable skin ulcers, often requiring limb amputation, and die prematurely from cardiovascular disease or cancer. For this debilitating…

